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Pseudomonas aeruginosa-induced corneal keratitis is a sight-threatening disease. The rise of antibi-
otic resistance among P. aeruginosa keratitis isolates makes treatment of this disease challeng-
ing, emphasizing the need for alternative therapeutic modalities. By comparing the responses
to P. aeruginosa infection between an outbred mouse strain (Swiss Webster, SW) and a suscep-
tible mouse strain (C57BL6/N), we found that the inherent neutrophil-killing abilities of these
strains correlatedwith their susceptibility to infection. Namely, SW-derived neutrophils were sig-
nificantly more efficient at killing P. aeruginosa in vitro than C57BL6/N-derived neutrophils. To
interrogate whether the distinct neutrophil killing capacities were dependent on endogenous or
exogenous factors, neutrophil progenitor cell lines were generated. The in vitro differentiated
neutrophils from either SW or C57BL6/N progenitors retained the differential killing abilities,
illustrating that endogenous factors conferred resistance. Consistently, quantitative LC-MS/MS
analysis revealed strain-specific and infection-induced alterations of neutrophil proteomes.
Among the distinctly elevated proteins in the SW-derived proteomes were 𝛼-mannosidases,
potentially associatedwithprotection. Inhibitionof𝛼-mannosidases reducedneutrophil bacterici-
dal functions in vitro. Conversely, topical applicationof𝛼-mannosidases reducedbacterial biofilms
and burden of infected corneas. Cumulatively, these data suggest novel therapeutic approaches to
control bacterial biofilm assembly and improve bacterial clearance via enzymatic treatments.
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1 INTRODUCTION
Eye trauma and contact lens use are the main factors that pre-
dispose to the development of infectious keratitis associated with
vision loss and blindness.1,2 In the United States, 1 in 2500 daily
contact wearers and 1 in 500 overnight lens wearers develop bac-
terial keratitis, which constitutes a significant health problem. The
organism that is most often isolated from contact lens–associated
corneal ulcers is Pseudomonas aeruginosa.3,4 Existing therapies often
fail to eradicate P. aeruginosa efficiently due to pathoadaptation and
acquired antibiotic resistance, marking the need to find alternative
Abbreviations: CHO, chinese hamster ovary; GCSF, granulocyte colony stimulating factor; PMN, polymorphonuclear cells
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therapeutic approaches.5 Therefore, there is a significant interest in
developing strategies to strengthen host resistance to infection.
The effective control and clearance of P. aeruginosa depends on
engulfment, phagocytosis, and degradation of bacteria in a complex
and highly regulated process that works in concert with other innate
immune responses, such as inflammatory signals. Genetic deficien-
cies that compromise phagocytosis, reactive oxygen species (ROS) pro-
duction, and phagocyte trafficking and adhesion result in a significant
predisposition to infection.6 In addition, bacteria harbor versatile
mechanisms to reduce phagocyte functionality. For example, P. aerug-
inosa alters the dynamics of cytoskeletal changes associated with
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phagocytosis, blocks ROS synthesis, and escapes phagocytic vacuoles
via effectors released by the type III secretion system.7–10
Although P. aeruginosa can proliferate in the cytosol of phagocytic
cells,11,12 the majority of it is present extracellularly. During chronic
infection, P. aeruginosa forms biofilms atmucosal sites, where it resides
in a nonmotile and protected from phagocytosis state. In biofilms,
bacteria increase the synthesis of extracellular polysaccharides (EPS)
to generate biomatrix in which the individual bacterial cells are
embedded. Three different types of polysaccharides—Psl, Pel, and
alginate—have been described as essential to biofilm formation.13–20
Importantly, the different polysaccharides demonstrate distinct
production kinetics, suggesting differential impact on the biofilm
growth.21 Whether P. aeruginosa forms biofilms during acute infec-
tions such as ocular keratitis remains controversial.22
Interestingly, in biofilms P. aeruginosa is surrounded by neu-
trophils, which fail to breach bacterial structures resulting in a lim-
ited host response.23 It is proposed that the EPS matrix that covers
P. aeruginosa biofilms inhibits complement activation and neutrophil
phagocytosis24,25 due to entrapped active enzymes, such as ecotin, a
Psl-binding protein with serine protease inhibitory that may inhibit
complement convertase activation. Here, we describe a mechanism of
biofilm decomposition activated in neutrophils derived from a strain of
mice resistant to keratitis. We show that the production of polysac-
charide degrading enzymes, including 𝛼-mannosidases, is elevated
leading to more efficient biofilm breakdown. We propose that the
production of enzymes that solubilize biofilms is a novelmechanism for
anti-bacterial protection. Ourwork suggests that these enzymes could
harbor therapeutic potential for treatment of infectious diseases.
2 MATERIALS AND METHODS
2.1 Ethics statement
All animal experiments were performed following National Institutes
of Health guidelines for housing and care of laboratory animals and
performed in accordance with institutional regulations after proto-
col review and approval by BWH IACUC committee and were consis-
tent with the Association for Research in Vision and Ophthalmology
guidelines for studies in animals (protocol 311).
2.2 Mice
Mice were housed and bred at the MCP Animal Care Facility. Swiss
Webster (SW) and C57BL/6N mice were purchased from Taconic
Farms (Rensselaer, NY). Seven- to 9-wk-old mice were used through-
out the experiments. We have not observed significant differences in
the bacterial clearance ofmale and femalemice to ocular P. aeruginosa-
induced infection.
2.3 Bacterial strains and inocula
Invasive P. aeruginosa clinical isolate 6294-GFP and PAO1-GFP strain
were used throughout the experiments. For the imaging experiments,
P. aeruginosa strains and clinical isolates PAO1, and 6354were electro-
porated with pCdrA-GFP (kindly provided by Prof. Tolker-Nielsen26)
and selected on gentamicin (15 𝜇g/ml). The bacterial strains were
grown overnight at 37◦C on Tryptic Soy Broth (TSB) (Cardinal Health,
Dublin, OH) agar plates supplemented with 5% sheep blood. Bacterial
suspensions were prepared in saline solution and used for subsequent
infection experiments.
2.4 Infectionmodel
Infections were carried out as described previously.27 Briefly, mice
were anesthetized with intraperitoneal ketamine and xylazine injec-
tions. Three 5mmscratchesweremade on the corneawith 25Gneedle
tip and an inoculum of 1 × 105 CFU of P. aeruginosa was delivered in
5 𝜇l onto the eye. Mice remained sedated for approximately 30 min.
For evaluation of corneal pathology, daily scores were recorded by
an observer unaware of the experimental conditions based on the
following scoring systemusing a graded scale of 0 to 4 as follows: 0, eye
macroscopically identical to the uninfected contra-lateral control eye;
1, faint opacity partially covering the pupil; 2, dense opacity covering
the pupil; 3, dense opacity covering the entire anterior segment; and 4,
perforation of the cornea, phthisis bulbi (shrinkage of the globe after
inflammatory disease), or both. To determine corneal bacterial counts
at 24 h after infection, mice were sacrificed, the eyes were enucleated,
and the corneas were dissected from the ocular surface. To quantify
P. aeruginosa levels, corneas were suspended in PBS, 0.05% Triton
X100, serially diluted and plated on P. aeruginosa selective McConkey
agar plates.
2.5 Purification of Polymorphonuclear cells (PMNs)
and bactericidal assays
Murine bone marrow was flushed from both hind limbs with PBS
supplemented with 2% FBS and 1 mM EDTA. The cells were washed,
erythrocytes in the cell pellet were lysed using theMouse Erythrolysis
Kit (R&D Systems, Minneapolis, MN) according to the manufacturer’s
instruction, and neutrophils were isolated using the EasySep Mouse
Neutrophil Enrichment Kit (Vancouver, Canada). Neutrophils were
incubated with P. aeruginosa strain PA01 at an MOI of 100:1 for
90 min at 37◦C on a rotator. Aliquots taken at time 0 and 90 min
were serially diluted and plated onMcConkey agar to determine num-
bers of live P. aeruginosa. Percentage of killing ability of neutrophils
was calculated.28
2.6 Neutrophil cell lines and treatments
SW and C57BL6/N neutrophil progenitor cell lines were established
as described in.29 Neutrophil progenitors were maintained in RPMI
supplemented with 10% FBS, penicillin-streptomycin, stem cell fac-
tor (SCF), and 𝛽-estradiol. The SCF was supplied as conditioned media
from a Chinese Hamster Ovary cell line engineered to produce SCF.
A total of 2% conditioned media was used, equating to a SCF concen-
tration of ∼100 ng/ml. The 𝛽-estradiol (Sigma, Ronkonkoma, NY, USA)
was dissolved in ethanol at 10 mM stock and used at a final concen-
tration of 0.5 𝜇M. To differentiate into granulocytes, 𝛽-estradiol was
omitted from the growthmedia, and cellswere cultured in RPMImedia
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supplemented with 20 ng/ml granulocyte colony stimulating fac-
tor (GCSF) (BioLegend, San Diego, CA, USA), 10% FBS, penicillin-
streptomycin, andmaintained for either 3 or 5 days before performing
the killing experiments. Typically, 1.5 × 106 granulocytes were either
treatedwith swainsonine (Tocris,Minneapolis,MN,USA) at a final con-
centrationof1𝜇g/mlor vehicle control for2–3hat37C5%CO2 before
adding or murine serum and P. aeruginosa 6294. The bactericidal assay
was performed as described above.
2.7 Intravital imaging
To image EPS, fluorescently labelled 0.5 𝜇gmAb to Psl Cam003,30 algi-
nate F42919 or control human IgG119 were topically applied to the
cornea for 15 min, ocular surface was washed thrice with 15 𝜇l of PBS
before imaging. To visualize neutrophils, C57BL6/Nmicewere injected
with 5 𝜇g fluorescently labelled anti-Ly6G (with either Alexa 674 or
APC) (Thermo Fisher Scientific, Bremen, Germany) IV for 30 min to
1 h before imaging.31 Video was acquired with an upright Olympus
FV1000 intravital microscope (Center Valley, PA, USA). The micro-
scope was equipped with a LumPlan 40×/0.8 numerical aperture (NA)
20× water immersion objective and digitally recorded with an Olym-
pusDP71 charge-coupled device video camera andOlympus FluoView
1000 imaging software. Some experiments were carried out using the
imaging system as described in.8 Images and 3D reconstructions were
carried out using Image J and MatLab. Areas covered with bacterial
biofilms were calculated and compared across different time points
of biofilm growth. Neutrophil meandering index was calculated per
individual tracks derived from at least 30 individual neutrophils per
separate imaging. Meandering index was calculated as a ratio of
displacement per individual track length.
2.8 Sample preparation for LC-MS/MS analysis
PMNs from infected and baseline SW and C57BL6/N mice (in tripli-
cate or quadruplicate) were subjected to in-solution trypsin digestion.
Briefly, 200 𝜇l of 8 M Urea containing 40 mM HEPES was added to
baseline and infected SW and C57BL6/N samples were sonicated in a
rotating water bath at 4◦C for 15 min (30 s on, 30 s off). The samples
were then reduced with 10 mM DTT, alkylated with 55 mM iodoac-
etamide (IAA), followed by dilution with 50 mM ammonium bicarbon-
ate to 2 M urea, and LysC and trypsin (protein: enzyme ratio 50:1)
digestion overnight. Digestion was stopped by addition of 10% v/v
trifluoroacetic acid (TFA) per sample and the acidified peptides were
loaded onto StageTips (containing three layers of C18) to desalt and
purify according to the standard protocol.32 Each sample was divided
onto two StageTips (one “working” and one “back-up”) and stored at
4◦C until the LC-MS/MSmeasurement.
2.9 LCMS/MSmeasurement
Samples were eluted from StageTips with 50 𝜇l buffer B (80% acetoni-
trile [ACN] and 0.5% acetic acid), the organic solvent was removed in
a SpeedVac concentrator for 20 min, and peptides were resuspended
in 10 𝜇l of buffer A (2% ACN and 0.1% TFA). 3 𝜇l of each sample was
analyzed by nanoflow liquid chromatography on an EASY-nLC system
(Thermo Fisher Scientific) online coupled to an Q Exactive HF-X
quadrupole orbitrap mass spectrometer (Thermo Fisher Scientific)
through a nanoelectrospray ion source (Thermo Fisher Scientific).
A 50 cm column with 75 𝜇m inner diameter was used for the chro-
matography, in-house packed with 3 𝜇m reversed-phase silica beads
(ReproSil-Pur C18-AQ, Dr. Maisch, GmbH, Ammerbuch, Germany).
Peptides were separated and directly electrosprayed into the mass
spectrometer using a linear gradient from 5% to 60% ACN in 0.5%
acetic acid over 120 min at a constant flow of 300 nl/min. The linear
gradient was followed by a washout with up to 95% ACN to clean the
column for the next run. The overall gradient length was 145 min. The
QExactive HF-X was operated in a data-dependent mode, switching
automatically between one full scan and subsequent MS/MS scans
of the fifteen most abundant peaks (Top15 method), with full scans
(m/z 300–1650) acquired in the Orbitrap analyzer with a resolution of
60,000 at 100m/z.
2.10 Raw data processing
Raw files were analyzed together using MaxQuant software (ver-
sion 1.5.6.2).33 The derived peak list was searched with the built-
in Andromeda search engine34,35against the reference Mus musculus
proteome downloaded from Uniprot (http://www.uniprot.org/) (April
27, 2016; 53,106 sequences). The parameters were as follows: strict
trypsin specificitywas requiredwith cleavage at theC-terminal after K
or R, allowing for up to two missed cleavages. The minimum required
peptide length was set to seven amino acids. Carbamidomethylation
of cysteine was set as a fixed modification (57.021464 Da) and N-
acetylation of proteins N termini (42.010565 Da) and oxidation of
methionine (15.994915 Da) were set as variable modifications. PSM
andprotein identificationswere filteredusing a target-decoy approach
at a false discovery rate (FDR) of 1%. ‘Match between runs’ was
enabled with a match time window of 0.7 min and an alignment time
window of 20 min. Relative, label-free quantification of proteins was
done using the MaxLFQ algorithm35 integrated into MaxQuant using
a minimum ratio count of 2, enabled FastLFQ option, LFQ minimum
number of neighbors at 3, and the LFQ average number of neighbors
at 6. The mass spectrometry proteomics data have been deposited in
the PRIDE partner repository for the ProteomeXchange Consortium
with the data set identifier: PXD009767.
2.11 Data analysis
Further analysis of the MaxQuant-processed data was performed
using the Perseus software environment (version 1.5.5.5).36 The “pro-
teingroups.txt” file was loaded into Perseus. Hits to the reverse
database, contaminants, and proteins only identified with modified
peptides were eliminated. LFQ intensities were converted to a log
scale (log2), and only those proteins which were present in triplicate
within at least one sample set were used for further statistical analy-
sis (valid-value filter of 3 in at least one group). Missing values were
imputed from a normal distribution (downshift of 1.8 standard devi-
ations and a width of 0.3 standard deviations). The total matrix was
imputed using these values, enabling statistical analysis. A Welch’s t
test was performed to identify proteins with a significant differential
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expression (P value < 0.05) between baseline and infected SW and
C57BL6/N (S0 = 1) samples employing a 5% permutation-based FDR
filter. A principle component analysis (PCA) was performed to deter-
mine proteome differences at the experiment level, as well as Pearson
correlationwith hierarchical clustering by Euclidean distance to deter-
mine replicate reproducibility. A two-sample Student’s t test (S0 = 1)
was performed on the entire data set and a 1D-annotation enrichment
based on the t test differences with a Benjamini-Hochberg FDR cutoff
at 0.05 allowed for visualization of enrichment by keywords within the
RStudio platform (http://www.R-project.org/). Specifically, annotation
enrichment categories meeting the P value (0.05) and FDR (0.05) cut-
offs, along with scores<−0.5 and<0.5 were plotted.
2.12 In vitro biofilm assays
Single colony of P. aeruginosa 6294was transferred to 3ml of LBmedia
and grown overnight to OD650 = 1.9 to 2.1. The overnight culture
was diluted to OD650 = 0.5 with M63 media and seeded into 96-well
plates for either 12 h at 37◦C. Wells were emptied, washed with PBS,
and 125 𝜇l of 0.5% crystal violet solution added into each well. After
15min incubation, plates werewashed 3 times by submerging into dis-
tilled water and blotting vigorously on paper towel. Plates were dried
overnight and 125 𝜇l of 30% acetic acid added into eachwell to solubi-
lize the crystal. Biofilms were quantified at 600 nm.
2.13 Mannosidase treatments
C57BL6/Nmice were infected with 5 × 105 CFU of P. aeruginosa 6294
delivered in 5 𝜇l onto the eye as described above. Alpha-mannosidase
(New England Biolabs, Ipswich, MA, USA) (0.2 U/cornea) were applied
topically every 3 h after the infectious challenge for the duration of
12 h.Micewere rested for 12 h and infected corneas harvested at 24 h
postinfectious challenge. The control group received topical aliquots of
mannosidase buffer.
2.14 Monoclonal antibody treatments
C57BL6/N mice were infected as described above with P. aeruginosa
6294 delivered in 5 𝜇l onto the eye as described above. A total of
400 𝜇g of anti-Psl mAb Cam 003 [30] or isotype control Ab were
applied topically every 6 h after the infectious challenge for the
duration of 24 h.
2.15 Statistical analysis
Statistical analysis of corneal pathology scores, bacterial burden, and
cytokine levels were either by unpaired Student’s t test upon nor-
mal distribution, Mann-Whitney U test for pairwise comparisons, or
one-way ANOVA with Dunn’s correction for multigroup comparisons
(Prism 4.0 for Macintosh). The analysis of the data from the bacterici-
dal activity assays was based on the use of unpaired Student’s t test or
One-way ANOVA as appropriate. Differences were considered signifi-
cant if the P value was<0.05 (Prism 4.0 forMacintosh).
3 RESULTS
3.1 Neutrophils fail to penetrate Psl-containing
P. aeruginosa biofilms at ocular surfaces
Biofilms are defined as clusters of bacteria encapsulated in EPS. Intrav-
ital detection of biofilms during keratitis has been challenging because
of a lack of EPS-specific reagents. Recent investigation based on
cryo-electron microscopy imaging showed that P. aeruginosa formed
bacterial microclusters on ocular surfaces, consistent with biofilm for-
mation, but the nature of the EPS was not explored.22 Using intravi-
tal imaging, we monitored P. aeruginosa PAO1 expressing CdrA-driven
GFP behavior during infection.26 This was combined with analysis of
the EPS composition by use of fluorescently labelled anti-PslmAbCam
003 that specifically recognizes Psl.30 During the early stages of infec-
tion, bacteria formed individual bacterial clusters or microcolonies
likely emanating from infected epithelial cells (early biofilms) (Fig. 1A),
whereas at later time points biofilms were observed where bacteria
resided in sheets (late biofilms) (Fig. 1A). Expectedly, bacterial biofilms
grew in size during infection (Fig. 1A). The biofilms were surrounded
with Psl (Fig. 1C). In contrast to Psl, low abundance of alginate pres-
ence was detected (data not shown) and the alginate-deficient clinical
P. aeruginosa isolate 6354 formed biofilms at ocular surfaces (data not
shown), indicative that alginate presence was not required for ocular
biofilm formation. Cumulatively, these data suggest that Psl is a domi-
nant polysaccharide among the ones tested making it a rational target
for treatment.
We utilized intravital imaging to directly monitor P. aeruginosa
behavior during ocular infection (Figs. 2 and S1) and found that bac-
terial biofilms were protected from neutrophil infiltration (Figs. 2, S1,
and S2). PMNs approached bacterial biofilms in swarms (Figs. 2A, top
right corner and S1). Individual PMNswere visible at the border of the
biofilms (Fig. 2A, yellow line) where they showed decreased motilities
when compared to the motilities of neutrophils within the swarm or at
sites where planktonic bacteria were visible (S1). Neutrophils probed
biofilms by extending phyllopodia against bacterial biofilms, but could
not easily penetrate biofilms (S2). These data suggest that interven-
tion strategies to disrupt biofilms could improve neutrophil function by
permitting access to bacteria themselves.
3.2 mAbs against Psl improves opsonophagocytosis
in vitro but shows no therapeutic efficacy in vivo
The use of Psl-specific mAbs was previously reported to demonstrate
good prophylactic efficacy in a lung and keratitis infectionmodels after
systemic administration.30 Here, we evaluated the opsonophagocytic
killing (OPK) activity of anti-Psl mAb Cam003 against keratitis iso-
lates, examined its bactericidal efficacy against P. aeruginosa grown in
a planktonic andmicro-aggregated forms, and its therapeutic ability in
vivo. Consistent with previous data the anti-Psl mAb Cam003 showed
significant OPK activity against keratitis clinical P. aeruginosa isolates
6294, 6354, and laboratory strain PAO1 (data not shown).30 Notably,
the OPK activity was diminished when P. aeruginosa was grown in
the presence of eukaryotic cells to allow micro-aggregate formation
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F IGURE 1 P. aeruginosa biofilms are sur-
rounded by psl. (A) C57BL6/Nmice were infected
with 1.105 CFU/eye P. aeruginosa PAO1 express-
ing CrdA-GFP. The intravital microscopy was
carried out at early (12 h) and late (24 h) postin-
fectious challenge. Individual mice were imaged
longitudinally. Areas coveredwith bacterialmicro-
colonies or biofilms were calculated using Image
J analysis. Each symbol represents individual
bacterial cluster/microcolony. Student’s t test.
(B) 3D-reconstructions of early and late bacterial
biofilms. Volumes of biofilms per image were
shown for comparison. (C) Biofilms were stained
with fluorescently labeled anti-Psl mAb Cam003
(red), which was applied topically 15 min before
imaging. Images were recorded at 40×. Psl (red)
staining was adjacent or co-localized to P. aerug-
inosa (green). All images are representative of
five individual experiments with 1–2 imaged mice
per experiment. Imaging across central cornea
revealed that bacterial microaggregates were
seen during early hours of infection, whereas
bacterial biofilms were formed as infection pro-
gressed. P. aeruginosa PAO1 CdrA-GFP (green)
clusters were surrounded by red Psl-stained
polysaccharide, consistent with the definition of a
biofilm
(Fig. 3A). However, despite these prominent in vitro effects, the topi-
cal application of Cam003 at 6 h following the infectious challengewas
not sufficient to diminish the bacterial corneal burden and the accom-
panying inflammation (Fig. 3B and C). No changes in neutrophil influx
were observed, as measured by corneal neutrophil elastase levels or
by neutrophil attracting cytokines IL-1𝛽 andMIP-2 (Fig. 3C).
3.3 SWmice are resistant to P. aeruginosa keratitis
To identify modalities that may promote efficient bacterial clearance,
we examined immune responses to P. aeruginosa-induced keratitis in
SW and C57BL6/N mice. Unlike the C57BL6/N mice, the SW mice
appeared resistant to infection and cleared P. aeruginosa (Fig. 4A).
This correlated with the ex vivo ability of SW-derived neutrophils
to kill P. aeruginosa more efficiently than the C57BL/6N-derived
neutrophils (Fig. 4B).
To identify potential molecular mechanisms responsible for the
improved bactericidal activity of SW-derived neutrophils, quantitative
proteomic analysis was performed on neutrophils derived from nonin-
fected (baseline) and P. aeruginosa–infected SW and C57BL6/N mice.
In total, 4297 proteins were identified from triplicate samples of SW
baseline, SW infected, C57BL6/N baseline, and C57BL6/N infected
cells. Biologic replicate reproducibility ranged from 92% to 95%. A
PCA demonstrated clear clustering of the biologic replicates (Fig. 5A)
and distinct patterns of protein responses among the strains and
treatments (component 1 at 37.2%; component 2 at 16.3%), illustrat-
ing active remodeling of the proteomes in the neutrophils derived
from the infected mice. The volcano plots compare the differentially
present proteins across genotypes (SW versus C57BL6/N). We iden-
tified 366 proteins with significant differences in abundance upon
comparison of PMN proteomes (Fig. 5B). Additionally, we identified
695 proteins with significant differences in abundance upon compar-
ison of PMN proteomes derived from infected SW and C57BL6/N
mice (Fig. 5C).
Interestingly, 1D annotation enrichment profiling based on key-
words of the significantly different neutrophil proteins (P value< 0.05;
FDR < 0.05) identified among the comparisons, revealed patterns
of enrichment between the proteomes of neutrophils derived from
infected C57BL6/N mice versus noninfected C57BL6/N mice (Fig. 5D
comparison 1) and between the proteomes of neutrophils derived
from the infected C57BL6/N and infected SW mice (Fig. 5D. compari-
son 4). These results suggest clear differences in neutrophil responses
during infection in the C57BL6/N strain, as well as differential neu-
trophil outcomes between the mouse strains. Namely, neutrophil
responses to infection included proteins associatedwith translocation,
splicesome formation, regulation of mRNA splicing, mRNA processing,
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F IGURE 2 Neutrophils do not penetrate bacterial
biofilms. C57BL6/N mouse was infected with 1 × 105
CFU/eye PAO1-GFP. Mice were given fluorescent anti-
Ly6G-Alexa 647 IV to label neutrophils. (A) Neutrophil
swamps were migrating towards bacterial biofilms
(green). Still image from S1. Bar size 72 𝜇m. (B) Meander-
ing indexes were calculated using MatLab and plotted.
Neutrophil motilities differed depending on whether
neutrophils appeared proximal to the biofilm (white
circles) or distal (orange circles). Proximally located PMNs
had significantly lower motilities when compared to the
ones within the swamps or at a distance where bacteria
were planktonic. Student’s t test. S1 movie is represen-
tative of three independent experiments. (C) Crawling
neutrophils (blue) probe the bacterial clusters (green)
(Still image from S2). P. aeruginosa PAO1 appear green,
less mobile, and individual bacterial cells visibly move
back and forth demonstrating restricted mobility within
microcolonies. The movie displays crawling neutrophils
that probe bacterial microcolonies, but do not enter
them. The movie is representative of more than three
independent experiments. Video recording, 50min
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F IGURE 3 Topical application of anti-psl MAb Cam003 is not protective. (A) Percent OPK of P. aeruginosa 6294 grown in a planktonic and
microaggregate form. The anti-Psl mAb Cam003 shows significant opsonophagocytic killing against 6294, which is decreased when bacteria are
allowed to form microaggregates in vitro. Student’s t test. (B) Topical application of 400 𝜇g of Cam 003 onto infected eyes does not improve bac-
terial clearance. The mAb-treated eyes show a 2-fold increase in bacterial presence. Student’s t test. P = 0.01. Data are representative of three
independent experiments. (C)No significant differences in tissue IL-1𝛽 , MIP-2, andNE levels amongCam003-treated and control Ab-treatedmice.
Student’s t test. Each symbol represents individual animals

















































F IGURE 4 SW mice are resistant to P. aeruginosa 6294-induced
keratitis. (A) Cohorts of SW (N = 9) and C57BL/6 (N = 5) mice were
infected with 1 × 106 CFU of P. aeruginosa 6294 and bacterial bur-
dens in the cornea quantified at 48 h after the onset of infection.
Student’s t test. Experiments were repeated trice. (B) SW-derived
PMNs kill P. aeruginosa 6294 more efficiently than C57BL6/N-derived
PMNs.Mature neutrophilswere purified frombonemarrowof SWand
C57BL/6N mice (stem cell), and exposed to 6294 at MOI 1 for 90 min
as in Dwyer and Gadjeva, and Ray. Aliquots from the reactions were
plated. Student’s t test. Data are representative of two independent
experiments
RNA-binding, and methylation. Positive enrichment of membrane-
associated proteins was also observed including transmembrane
proteins, transmembrane helix proteins, and mitochondrion inner
membrane proteins, which suggests that processes of cellular
remodeling are involved. Finally, secreted proteins and proteins of the
endoplasmic reticulum were positively enriched, indicating secretory
pathway involvement as a response to infection, whichmay be a poten-
tial connection with the observed 𝛼-mannosidase activity and secre-
tion. Similarities in lower-limit enrichmentwas observed for enzymatic
processes (e.g., ligase, serine/threonine-protein kinase, GTPase acti-
vation, and Ubl conjugation), cellular compartments (e.g., cytoplasm),
and general cellular processes (e.g., ATP-binding), suggesting reduced
involvement during infection. Conversely, strain-specific differ-
ences in neutrophil responses through positive enrichment showed
differential responses of lectin and calcium-associated pathways,
indicating changes in cellular processes and metabolism. Additionally,
differences in lower-limit enrichment included differences in kinase,
hydrolase, transferase, and nucleotide-binding categories, associated
with post-translational modifications and cellular regulation.
Only two categories of proteins stood out when comparing the1D
annotation enrichment keyword profiling between infected SWversus
baseline SW (Fig. 5D-2) and baseline C57BL6/N versus baseline SW
(Fig. 5D-3) proteomes. These included responses associatedwith post-
translational modifications by acetylation which are typically involved
in cell signaling, thereby enabling differential cellular reactions to
perturbations, suggestive of infection-associated and strain-specific
responses (Fig. 5D). Conversely, chaperone-associated proteins were
positively enriched in a strain-specific manner, indicating changes in
protein folding and cellular stress response. Taken together, these
results demonstrated clear differences in protein enrichment profiles
between baseline and infection, as well as strain-specific responses,
which likely contributed to the overall observations of differential neu-
trophil killing abilities between themice strains.
Specifically, the abundance of lysosomal proteins with enzymatic
activities were of particular interest due to differential patterns of
regulation in the SW-derived PMNs at baseline and during infection.
Namely, chitotriosidase-1 (Chit1) showed a 5.9- and 5.3-fold increase
in abundance at baseline and during infection, respectively, as com-
pared to C57BL/6N-derived proteomes; cathepsin E (CtsE) showed
a 4.0-fold increase in abundance at baseline and during infection,
respectively, as compared to the proteomes from C57BL/6N-derived
neutrophils. Lysosomal 𝛼-mannosidase (Man2b1) showed a 5.0- and
2.9-fold increase in abundance at baseline and during infection,
respectively, as compared to C57BL/6N neutrophils (Fig. 5B and
C). Also of interest was 𝛼-mannosidase (Man2c1) which showed a
5.4-fold increase in abundance in infected SW-derived neutrophils
as compared to infected C57BL/6N-derived neutrophils, but was not
significantly different at baseline (Fig. 5C). Cumulatively, these data
suggested that SW-derived neutrophils aremore capable of producing
proteins with anti-inflammatory and antimicrobial activities than their
C57BL/6N counterparts. Further, our data showed that infection
altered neutrophil proteomes demonstrating that these cells were
significantly more plastic than previously appreciated and suggestive
that the changes fine-tuned neutrophil responses to pathogens.
3.4 Neutrophil cell intrinsic characteristics govern
their superior bactericidal capacity against P.
aeruginosa
To examine whether the differential killing of P. aeruginosa had cell-
intrinsic component, neutrophil progenitor cell lines were devel-
oped from the bone marrow of both SW or C57BL6/N mice and
allowed to mature in vitro to neutrophils (Fig. 6A). To verify that cell-
intrinsic characteristics are responsible for differential killing of P.
aeruginosa, SW-derived and C57BL/6N-derived neutrophil cell lines
were matured with GCSF and their bactericidal capacities examined.
Electron microscopy-based analysis of matured cells demonstrated
appearance of cells with typical multilobed nuclei, characteristic to
PMNs (Fig. 6A). Similar to thedata generatedwith primary neutrophils,
the in vitro SW-derived neutrophils were better at killing P. aeruginosa
when compared to C57BL6/N-derived neutrophils (Fig. 6B, one-way
ANOVA) evenwhen exposed to GCSF priming.
To verify that the bactericidal activity of SW-derived neutrophils
was dependent on 𝛼-mannosidases, GCSF-primed SW neutrophil
cell line or bone marrow-derived primary neutrophils were pre-
treated with the 𝛼-mannosidase inhibitor swainsonine and chal-
lenged with P. aeruginosa (Fig. 6C and D). In either of the com-
parisons, the SW neutrophil bactericidal activities were significantly
reduced by swainsonine treatment (Fig. 6C, P = 0.007, Student’s t
test and Fig. 6D, P = 0.02, Student’s t test), confirming the con-
tribution of 𝛼−mannosidase in P. aeruginosa killing. Cumulatively,
these data suggest that 𝛼-mannosidase facilitates bactericidal function
of neutrophils.
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F IGURE 5 Differential protein abundance in SWandC57BL6/N-derived neutrophils frombaseline andP. aeruginosa-infectedmice. (A) Princi-
ple component analysis representing the proteomes of samples harvested from neutrophils derived from noninfected SW (red) and C57BL/6mice
(blue), and infected SW (orange) and C57BL/6 (green) mice. Experiment was performed with a minimum of biological triplicates and measured on
themass spectrometer in two independentexperiments. (B)Volcanoplotdepicting all identifiedproteins inneutrophils harvested fromnoninfected
SW and C57BL/6 mice. The significantly different proteins with an increase in abundance at baseline in SWmice are shown in red, whereas those
in the C57BL6-derived neutrophils are shown in blue. Data are representative from two independent experiments performed in at least biological
triplicate. A Welch’s t test was performed to determine significant differences in protein abundance (P value < 0.05) using Benjamini-Hochberg
FDR correction at 5%. The position of Man2b1 is highlighted. (C) Volcano plot depicting neutrophil proteomes from infected SW and C57BL/6
mice. The significantly different proteins with an increase in abundance during infection in SW mice are shown in orange, whereas those in the
C57BL/6-derived neutrophils are shown in green. Data are representative from two independent experiments performed in at least biological trip-
licate. A Welch’s t test was performed to determine significant differences in protein abundance (P value < 0.05) using Benjamini-Hochberg FDR
correction at 5%. The position ofMan2b1 andMan 2c1 are highlighted. (D) 1D annotation enrichment profile based on keywords for comparisons
amongbaseline and infected SWandC57BL/6-derived neutrophil samples.Data are representative from two independent experiments performed
in at least biological triplicate. A two-sample Student’s t test was performed (P value< 0.05) using Benjamini-Hochberg FDR correction at 5%with
scores between<−0.5 and<0.5
3.5 𝜶-mannosidase treatment reduces bacterial
burden during keratitis
Given that Psl is a mannose-rich polysaccharide and that 𝛼-
mannosidase digests,37 the biofilm-reducing capacity of exogenously
added 𝛼-mannosidasewas examined. Bacterial biofilms of P. aeruginosa
6294 were grown for 24 h and treated with 𝛼-mannosidase for 3 h
at 37◦C after biofilms had formed. Mannosidase treatment signifi-
cantly reduced biofilm density (Fig. 7A, Student’s t test, P = 0.006).
Further, a cyclic Di-GMP reporter PAO1 strain was allowed to form
biofilms and was subsequently treated with 𝛼-mannosidase. The
decrease in reporter-based fluorescence upon treatment accompa-
nied the reduction in Psl-based biofilm formation (Fig. 7B, Student’s
t test, P = 0.02). Last, C57BL6/N mice were treated topically with
𝛼-mannosidase every 3 h for 12 h after the infectious challenge.
Mice receiving topical mannosidase exhibited reduced bacterial
burden when compared to the placebo-treated mice (Student’s t test,
P= 0.008) (Fig. 7C).
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F IGURE 6 Swainsonine inhibits SW neu-
trophil bactericidal activities against P.
aeruginosa. (A) Electron micrograph image of
SW-cell line derived PMNs phagocytosing P.
aeruginosa. Individual bacterial cells engulfed
by the PMN are shown with arrows. (B) In vitro
generated SW and C57BL6/N neutrophils were
primed with GCSF and exposed to P. aerugi-
nosa. Percent bacterial killing was calculated.
One-way ANOVA. Data demonstrate that SW-
derived neutrophils retain superior bactericidal
activity over C57BL/6N neutrophils. Data are
representative from one out of four individual
experiments. (C) In vitro generated, primed
with GCSF SW neutrophils were exposed
swainsonine (SW+S) or vehicle control (SW)
and challenged with P. aeruginosa 6294. Percent
bacterial killing was calculated. Student’s t test.
Data are representative of two experiments.
(D) Bone marrow-derived SW neutrophils
were exposed to swainsonine and P. aerugi-
nosa. Percent bacterial killing was calculated.
Student’s t test
4 DISCUSSION
To date, the in-depth analysis of bacterial biofilms at ocular surfaces
has been hindered by the lack of information about the nature of the
bacterial polysaccharides in the matrix, lack of polysaccharide specific
antibodies, imaging that requires tissue fixation and ex vivo analysis of
corneas.22 Using intravital imaging in live animals, we demonstrated
that ocular P. aeruginosa biofilms are Psl rich. Consequently, our data
suggest a niche-specific adaptation of P. aeruginosa. Based on these
observations we reason that treatment of ocular keratitis could be tai-
lored to that niche.
Although the majority of keratitis isolates produce Psl,18 we can-
not exclude contributions from other polysaccharides or matrix com-
ponents in P. aeruginosa biofilms. For example, it is known that PA14
lacks Psl, is virulent in ocular keratitismodels. Hence, it is likely that Psl
is sufficient for P. aeruginosa pathoadaptation to the ocular niche, but
not required.
Interestingly, the administration of the anti-Psl mAb was not
sufficient to ameliorate keratitis, despite its excellent in vitro OPK
characteristics. Indeed, we observed a 2-fold increase in the recovered
bacteria from the infected corneas of the mAb-treated group (Fig. 3).
A possible explanation is lack of penetrance of neutrophils inside
the biofilm even when biofilm were covered with anti-Psl- specific
antibodies. Fewer neutrophils were present at the surface or close to
the surface of the biofilms, whereas the majority of the neutrophils
appeared under the biofilms, within the epithelial and/or stromal layer
of the eye. Because Psl covered and surrounded bacterial biofilms at
the ocular surface, the lack of therapeutic effectmay be explainedwith
the reduced neutrophil presence. Alternatively, defects in ability of
neutrophils to digest biofilms even in the presence of polysaccharide-
specific antibodiesmay contribute to the process, whichwould be con-
sistent with the data presented here. Last, additional virulence factors
may impair neutrophil functionality in the vicinity of biofilms. Given
the recently reported benefit of the bispecific anti-Psl and anti-PcrV
antibody in multiple animal infection models,8,38,39 it is likely that tar-
geting of the type III secretion system is needed to confer protection.
To identify modalities that promote efficient bacterial clearance,
we examined immune responses to P. aeruginosa-induced keratitis in
SW and C57BL6/N mice. Unlike the C57BL6/N mice, the SW mice
appeared resistant to infection and cleared P. aeruginosa in vivo. This
correlated with the ability of SW-derived neutrophils to kill P. aerugi-
nosa in vitro more efficiently than C57BL/6N-derived neutrophils.
To identify potential mechanisms for improved bactericidal activ-
ity, we used quantitative LC-MS approach. We identified more than
4000 total proteins per neutrophil proteome, which exceeds signif-
icantly the pool of 2000 proteins reported in previous proteomic
studies.40–43 Based on our proteomic data, we identified infection and
strain-specific differences in the neutrophil proteomic networks.
For the purposes of this particular investigation we chose to focus
on 𝛼-mannosidases that were significantly more abundant in the neu-
trophils derived from the SWmice, suggestive of their contribution to
protective immunity. Because Psl is a polymer of pentameric repeating
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F IGURE 7 Alpha mannosidase treatment facilitates P. aeruginosa clearance in C57BL6/N mice. (A) P. aeruginosa 6294 was allowed to form
biofilms in vitro for 24 h and were exposed to 10 U of 𝛼-mannosidase for 2 h at 37◦C. Bacterial biofilms stained and measured. Student’s t test.
(P= 0.006). Data are representative of two experiments. (B) P. aeruginosa PAO1-CrdA-GFPwas allowed to form biofilms in vitro for 24 h and were
exposed to 10 U of 𝛼-mannosidase for 2 h at 37◦C. Bacterial biofilms were washed, and fluorescent signal measured. Student’s t test. (P = 0.05).
Data are representative of two independent experiments. (C) C57BL/6Nwere infected with P. aeruginosa 6294 at 1.106 CFU/cornea, treated with
0.2 U/drop 𝛼-mannosidase four times daily, starting at 12 h post the onset of infection. Student’s t test, (P = 0.01). Data are representative of two
independent experiments with 5mice per group
units of D-mannose, L-rhamnose, and D-glucose, where the individual
𝛼-D-mannose residues are connected with linkages, suitable for
digest by the identified via LC-MS/MS 𝛼-mannosidases (e.g., Man2b1),
we tested the importance of 𝛼-mannosidases in regulating biofilm
formation and bactericidal properties of neutrophils. Consistent
with recently published data by others,44 we observed that treat-
ment with 𝛼-mannosidase in vitro decreased P. aeruginosa biofilms.
Another recent study demonstrated that 𝛼-mannosidase targeted
Psl.37 Furthermore, Psl inhibited neutrophil bactericidal activity37 and
protected bacteria from proteolytic attach by neutrophil elastase.25
We confirmed and expanded on this foundation by providing evidence
that neutrophil-derived 𝛼- mannosidase activity is needed for optimal
bactericidal function against P. aeruginosa and that the topical appli-
cation of 𝛼-mannosidase decreased corneal bacterial burden in vivo
at least initially during infection (Fig. 7). Cumulatively, these findings
suggested that exogenous 𝛼-mannosidases alter Psl structure in such
a way that render P. aeruginosamore susceptible to killing.
In humans, 𝛼-mannosidase is present in the lysosomes and is
secreted extracellularly45,46 Mutations that impair lysosomal 𝛼-
mannosidase (Man2b1) activity causedevelopment of 𝛼-mannosidosis,
a condition that is rare, autosomal recessive, and multisystemic. This
progressive lysosomal storage disorder results in facial and skeletal
abnormalities, motor impairment, hearing impairment, intellectual dis-
ability, immune deficiency, and recurrent infections.47 Importantly, the
recombinant human 𝛼-mannosidase shows promise in clinical trials
for enzyme replacement therapy.48 The recombinant 𝛼-mannosidase
is well tolerated; the frequency of infusion-related reactions and the
development of allo-antibodies are low compared to other enzyme
replacement therapies.48 These findings are exciting as they suggest
that the use of recombinant human 𝛼-mannosidase for treatment of
other conditions such as treatment of biofilm-based infections may be
feasible andwell tolerated.
The pool of differentially expressed proteins also included addi-
tional proteins such as cathepsin E (4.7-fold), CD14 (2.5-fold),
and Chit1 (3.6-fold). Previous studies have documented that CD14
deficiency was associated with altered kinetics of P. aeruginosa-
induced keratitis, implicating CD14-triggered pathways in promoting
inflammation-induced corneal tissue damage in the C57BL/6 mice.49
Consistently, Chit1 deficiency altered inflammatory responses to K.
pneumoniae in the infected lungs of C57BL6 mice, resulting in less
pathology.50 Last, overexpression of cathepsin E was associated with
alterations in the kinetics of phagolysosomal assembly, terminating
phagolysosomal maturation.51 Cumulatively, these data illustrate that
the infected SW-derived PMNs had proteomes that bear unique fea-
tures, reflective of distinct neutrophil functions that were associ-
ated with improved recovery. It is of our current interest to find out
how to leverage this knowledge therapeutically to promote resolution
of infection.
KUGADAS ET AL. 1109
AUTHORSHIP
A.K., R.M., E.G., and M.G. performed experiments and analyzed data.
J.G.-M. generated and analyzed the LC-MSdata.D.B.S. andM.K.M. pro-
vided insight and helped generating PMN cell lines. A.DG. provided
the anti-psl MoAb. M.G. conceptualized the study, analyzed data, and
wrote themanuscript. All authors critically read themanuscript.
ACKNOWLEDGMENTS
This work was supported by NIH-NEI RO1 EY022054 to M.G. The
authors thank Dr. Ajitha Thanabalasuriar and Prof. P. Kubes (Univer-
sity of Calgary, Canada) for providing expertise and help during the ini-
tial experiments of imaging of bacterial biofilms. They also thankMaria
Ericsson (Harvard ElectronMicroscopy [EM] core) for EM analysis.
DISCLOSURES
A.DG. has interests in developing anti-Psl-MoAb-based therapies.
REFERENCES
1. Robertson DM, Petroll WM, Jester JV, Cavanagh HD. The role of con-
tact lens type, oxygen transmission, and care-related solutions inmedi-
ating epithelial homeostasis andpseudomonasbinding to corneal cells:
an overview. Eye Contact Lens. 2007;33:394-398. discussion 399-400.
2. Robertson DM, Petroll WM, Jester JV, Cavanagh HD. Current con-
cepts: contact lens related Pseudomonas keratitis. Cont Lens Anterior
Eye. 2007;30:94-107.
3. Fleiszig SM, Evans DJ. The pathogenesis of bacterial keratitis: studies
with Pseudomonas aeruginosa. Clin Exp Optom. 2002;85:271-278.
4. Fleiszig SM, TheGlennA. Fry award lecture 2005. The pathogenesis of
contact lens-related keratitis.Optom Vis Sci. 2006;83:866-873.
5. O’Brien TP, MaguireMG, Fink NE, Alfonso E, McDonnell P. Efficacy of
ofloxacin vs cefazolin and tobramycin in the therapy for bacterial ker-
atitis. Report from the Bacterial Keratitis Study Research Group. Arch
Ophthalmol. 1995;113:1257-1265.
6. Andrews T, Sullivan KE. Infections in patients with inherited defects in
phagocytic function. Clin Microbiol Rev. 2003;16:597-621.
7. Vareechon C, Zmina SE, Karmakar M, Pearlman E, Rietsch A. Pseu-
domonas aeruginosa effector ExoS inhibits ROS production in human
neutrophils. Cell Host Microbe. 2017;21:611-618. e5.
8. Thanabalasuriar A, Surewaard BG, Willson ME, et al. Bispecific anti-
body targets multiple Pseudomonas aeruginosa evasion mechanisms
in the lung vasculature. J Clin Invest. 2017;127:2249-2261.
9. Lovewell RR, Patankar YR, Berwin B.Mechanisms of phagocytosis and
host clearance of Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol
Physiol. 2014;306:L591-603.
10. Fleiszig SM, Evans DJ, Do N, Vallas V, Shin S, Mostov KE. Epithelial
cell polarity affects susceptibility toPseudomonas aeruginosa invasion
and cytotoxicity. Infect Immun. 1997;65:2861-2867.
11. Fleiszig SM, Zaidi TS, Fletcher EL, Preston MJ, Pier GB. Pseudomonas
aeruginosa invades corneal epithelial cells during experimental infec-
tion. Infect Immun. 1994;62:3485-3493.
12. Fleiszig SM, Zaidi TS, Pier GB. Pseudomonas aeruginosa invasion of
and multiplication within corneal epithelial cells in vitro. Infect Immun.
1995;63:4072-4077.
13. Jennings LK, Storek KM, Ledvina HE, et al. Pel is a cationic exopolysac-
charide that cross-links extracellular DNA in the Pseudomonas aerug-
inosa biofilmmatrix. Proc Natl Acad Sci U S A. 2015;112:11353-11358.
14. ParsekMR. Controlling the Connections of Cells to the BiofilmMatrix.
J Bacteriol. 2016;198:12-14.
15. Ma L, Lu H, Sprinkle A, Parsek MR, Wozniak DJ. Pseudomonas aerug-
inosa Psl is a galactose- and mannose-rich exopolysaccharide. J Bacte-
riol. 2007;189:8353-8356.
16. ColvinKM, IrieY, TartCS, et al. ThePel andPsl polysaccharidesprovide
Pseudomonas aeruginosa structural redundancy within the biofilm
matrix. EnvironMicrobiol. 2012;14:1913-1928.
17. Zhao K, Tseng BS, Beckerman B, et al. Psl trails guide exploration and
microcolony formation in Pseudomonas aeruginosa biofilms. Nature.
2013;497:388-391.
18. Zegans ME, DiGiandomenico A, Ray K, et al. Association of biofilm
formation, Psl exopolysaccharide expression, and clinical out-
comes in Pseudomonas aeruginosa keratitis: analysis of isolates
in the steroids for corneal ulcers trial. JAMA Ophthalmol. 2016;134:
383-389.
19. Zaidi T, Pier GB. Prophylactic and therapeutic efficacy of a fully human
immunoglobulin G1 monoclonal antibody to Pseudomonas aerugi-
nosa alginate in murine keratitis infection. Infect Immun. 2008;76:
4720-4725.
20. Ma L, Conover M, Lu H, Parsek MR, Bayles K, Wozniak DJ. Assembly
and development of the Pseudomonas aeruginosa biofilmmatrix. PLoS
Pathogens. 2009;5:e1000354.
21. Ghafoor A, Hay ID, Rehm BH. Role of exopolysaccharides in Pseu-
domonas aeruginosa biofilm formation and architecture. Appl Environ
Microbiol. 2011;77:5238-5246.
22. Saraswathi P, Beuerman RW. Corneal biofilms: from planktonic to
microcolony formation in an experimental keratitis infection with
Pseudomonas aeruginosa.Ocular Surf. 2015;13:331-345.
23. Kragh KN, AlhedeM, Jensen PO, et al. Polymorphonuclear leukocytes
restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibro-
sis patients. Infect Immun. 2014;82:4477-4486.
24. Mishra M, Byrd MS, Sergeant S, et al. Pseudomonas aeruginosa
Psl polysaccharide reduces neutrophil phagocytosis and the oxida-
tive response by limiting complement-mediated opsonization. Cell
Microbiol. 2012;14:95-106.
25. Tseng BS, Reichhardt C, Merrihew GE, et al. A biofilm matrix-
associated protease inhibitor protects Pseudomonas aeruginosa from
proteolytic attack.MBio. 2018;9.
26. Rybtke MT, Borlee BR, Murakami K, et al. Fluorescence-based
reporter for gauging cyclic di-GMP levels in Pseudomonas aeruginosa.
Appl EnvironMicrobiol. 2012;78:5060-5069.
27. PrestonMJ, Fleiszig SM, Zaidi TS, et al. Rapid and sensitivemethod for
evaluating Pseudomonas aeruginosa virulence factors during corneal
infections in mice. Infect Immun. 1995;63:3497-3501.
28. Dwyer M, Gadjeva M. Opsonophagocytic assay. Methods Mol Biol.
2014;1100:373-379.
29. Odegaard JI, Vats D, Zhang L, et al. Quantitative expansion of
ES cell-derived myeloid progenitors capable of differentiating into
macrophages. J Leukoc Biol. 2007;81:711-719.
30. DiGiandomenico A, Warrener P, Hamilton M, et al. Identification
of broadly protective human antibodies to Pseudomonas aerugi-
nosa exopolysaccharide Psl by phenotypic screening. J Exp Med.
2012;209:1273-1287.
31. Kolaczkowska E, Jenne CN, Surewaard BG, et al. Molecular mecha-
nisms ofNET formation anddegradation revealed by intravital imaging
in the liver vasculature.Nat Commun. 2015;6:6673.
32. Rappsilber J, Mann M, Ishihama Y. Protocol for micro-purification,
enrichment, pre-fractionation and storage of peptides for proteomics
using StageTips.Nat Protoc. 2007;2:1896-1906.
1110 KUGADAS ET AL.
33. Cox J, Mann M. MaxQuant enables high peptide identification rates,
individualized p.p.b.-range mass accuracies and proteome-wide pro-
tein quantification.Nat Biotechnol. 2008;26:1367-1372.
34. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M.
Andromeda: a peptide search engine integrated into the MaxQuant
environment. J Proteome Res. 2011;10:1794-1805.
35. Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M. Accurate
proteome-wide label-free quantification by delayed normalization and
maximal peptide ratio extraction, termedMaxLFQ.Mol Cell Proteomics.
2014;13:2513-2526.
36. Tyanova S, Temu T, Sinitcyn P, et al. The Perseus computational plat-
form for comprehensive analysis of (prote)omics data. Nat Methods.
2016;13:731-740.
37. Hill PJ, Scordo JM, Arcos J, et al.Modifications of Pseudomonas aerug-
inosa cell envelope in the cystic fibrosis airway alters interactionswith
immune cells. Sci Rep. 2017;7:4761.
38. Le HN, Quetz JS, Tran VG, et al. MEDI3902 correlates of protection
against severe Pseudomonas aeruginosa pneumonia in a rabbit acute
pneumoniamodel. Antimicrob Agents Chemother. 2018:62.
39. DiGiandomenico A, Keller AE, Gao C, et al. Amultifunctional bispecific
antibody protects against Pseudomonas aeruginosa. Sci Transl Med.
2014;6:262ra155.
40. Loi ALT, Hoonhorst S, van Aalst C, et al. Proteomic profiling of periph-
eral blood neutrophils identifies two inflammatory phenotypes in sta-
ble COPD patients. Respir Res. 2017;18:100.
41. Tak T,Wijten P, HeeresM, et al. Human CD62L(dim) neutrophils iden-
tified as a separate subset by proteome profiling and in vivo pulse-
chase labeling. Blood. 2017;129:3476-3485.
42. McLeish KR, Merchant ML, Klein JB, Ward RA. Technical note: pro-
teomic approaches to fundamental questions about neutrophil biol-
ogy. J Leukoc Biol. 2013;94:683-692.
43. Serwas NK, Huemer J, Dieckmann R, et al. CEBPE-mutant spe-
cific granule deficiency correlates with aberrant granule organization
and substantial proteome alterations in neutrophils. Front Immunol.
2018;9:588.
44. Banar M, Emaneini M, Satarzadeh M, et al. Evaluation of mannosi-
dase and trypsin enzymes effects on biofilm production of Pseu-
domonas aeruginosa isolated from burn wound infections. PloS one.
2016;11:e0164622.
45. Rose DR. Structure, mechanism and inhibition of Golgi alpha-
mannosidase II. Current Opin Struct Biol. 2012;22:558-562.
46. TasegianA, Paciotti S, CeccariniMR, et al. Origin of alpha-mannosidase
activity in CSF. Int J Biochem Cell Biol. 2017;87:34-37.
47. Borgwardt L, Lund AM, Dali CI. Alpha-mannosidosis - a review of
genetic, clinical findings and options of treatment. Pediatr Endocrinol
Rev. 2014;12(Suppl 1):185-191.
48. Borgwardt L, Dali CI, Fogh J, et al. Enzyme replacement ther-
apy for alpha-mannosidosis: 12 months follow-up of a single cen-
tre, randomised, multiple dose study. J Inherit Metabol Dis. 2013;36:
1015-1024.
49. Roy S, Karmakar M, Pearlman E. CD14 mediates toll-like receptor
4 (TLR4) endocytosis and spleen tyrosine kinase (Syk) and inter-
feron regulatory transcription factor 3 (IRF3) activation in epithelial
cells and impairs neutrophil infiltration and Pseudomonas aeruginosa
killing in vivo. J Biol Chem. 2014;289:1174-1182.
50. Sharma L, Amick AK, Vasudevan S, et al. Regulation and role of
chitotriosidase during lung infection with Klebsiella pneumoniae.
J Immunol. 2018;201:615-626.
51. Tsukuba T, Yanagawa M, Kadowaki T, et al. Cathepsin E defi-
ciency impairs autophagic proteolysis in macrophages. PloS one.
2013;8:e82415.
52. Ray VA, Hill PJ, Stover CK, et al. Anti-Psl Targeting of Pseudomonas
aeruginosa Biofilms for Neutrophil-Mediated Disruption. Sci Rep.
2017;7:16065.
SUPPORTING INFORMATION
Additional informationmay be found online in the Supporting Informa-
tion section at the end of the article.
How to cite this article: Kugadas A, Geddes-McAlister J, Guy
E, et al. Employing enzymatic treatment options for manage-
ment of ocular biofilm-based infections. J LeukocBiol. 2019;105:
1099–1110. https://doi.org/10.1002/JLB.4HI0918-364RR
